SAN DIEGO & HAYWARD, Calif.--(BUSINESS WIRE)--Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of Pulse Biosciences, Inc. (NasdaqCM: PLSE) breached their fiduciary duties to shareholders. On July 31, 2018, Pulse disclosed that it had received subpoenas from the U.S. Securities and Exchange Commission requesting documents and information related to an investigation into trading in the company's stock in advance of its September 2017 financing announcement. Pulse further revealed that on July 30, 2018, the company received a letter from Nasdaq stating that Pulse is not in compliance with Nasdaq's audit committee requirements and has until July 27, 2019 to regain compliance.
View this information on the law firm's Shareholder Rights Blog: https://www.robbinsarroyo.com/pulse-biosciences-inc-aug-2018/
Pulse Biosciences Shareholders Have Legal Options
If you would like more information about your rights and potential remedies, contact attorney Leonid Kandinov at (800) 350-6003, LKandinov@robbinsarroyo.com, or via the shareholder information form on the firm's website.
Robbins Arroyo LLP is a nationally recognized leader in shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested. Sign up for our FREE portfolio monitoring service, Stock Watch.
Attorney Advertising. Past results do not guarantee a similar outcome.
